Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress

As a number of disease-modifying anti-rheumatic drugs often have side effects at high doses and/or during long-term administration, increased efficacy without increased toxicity is expected for combination therapy of rheumatoid arthritis (RA). The safety of long-term therapy of RA is very important...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauerová, Katarína, Poništ, Silvester, Mihalová, Danica, Dráfi, František, Kuncírová, Viera
Formato: Texto
Lenguaje:English
Publicado: Slovak Toxicology Society SETOX 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090052/
https://www.ncbi.nlm.nih.gov/pubmed/21577282
http://dx.doi.org/10.2478/v10102-011-0007-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090052/
https://www.ncbi.nlm.nih.gov/pubmed/21577282
http://dx.doi.org/10.2478/v10102-011-0007-9

Ejemplares similares